1. Fornari A, Piva R, Chiarle R, et al. Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma? Hematol Oncol. 2009; 27:161–170.
2. Inghirami G, Pileri SA. European T-Cell Lymphoma Study Group. Anaplastic large-cell lymphoma. Semin Diagn Pathol. 2011; 28:190–201.
3. Medeiros LJ, Elenitoba-Johnson KS. Anaplastic large cell lymphoma. Am J Clin Pathol. 2007; 127:707–722.
4. Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Experiment Ophthalmol. 2008; 36:564–578.
5. Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol. 2004; 242:901–913.
6. Coupland SE, Anastassiou G, Bornfeld N, et al. Primary intraocular lymphoma of T-cell type: report of a case and review of the literature. Graefes Arch Clin Exp Ophthalmol. 2005; 243:189–197.
7. Levy-Clarke GA, Greenman D, Sieving PC, et al. Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature. Surv Ophthalmol. 2008; 53:285–295.
8. Kohno T, Uchida H, Inomata H, et al. Ocular manifestations of adult T-cell leukemia/lymphoma. A clinicopathologic study. Ophthalmology. 1993; 100:1794–1799.
9. Shibata K, Shimamoto Y, Nishimura T, et al. Ocular manifestations in adult T-cell leukemia/lymphoma. Ann Hematol. 1997; 74:163–168.
10. Mashayekhi A, Shields CL, Shields JA. Iris involvement by lymphoma: a review of 13 cases. Clin Experiment Ophthalmol. 2013; 41:19–26.
11. Shields CL, Shields JA, Shields MB, Augsburger JJ. Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors. Ophthalmology. 1987; 94:839–846.
12. Kim WI, Larar JG, Cheson BD, et al. Resolution of lymphoma-associated open-angle glaucoma by rituximab. J Glaucoma. 2011; 20:398–400.
13. Matsui N, Kamao T, Azumi A. Case of metastatic intraocular malignant lymphoma with neovascular glaucoma. Nihon Ganka Gakkai Zasshi. 2005; 109:434–439.
14. Berthold S, Kottler UB, Frisch L, et al. Secondary glaucoma in hyphema, hypopyon, iris prominence and iris hyperemia. Ophthalmologe. 2005; 102:290–292.
15. Patel AS, Hemady RK, Rodrigues M, et al. Endogenous Fusarium endophthalmitis in a patient with acute lymphocytic leukemia. Am J Ophthalmol. 1994; 117:363–368.
16. Gupta SR, Agnani S, Tehrani S, et al. Endogenous Streptococcus agalactiae (Group B Streptococcus) endophthalmitis as a presenting sign of precursor T-cell lymphoblastic leukemia. Arch Ophthalmol. 2010; 128:384–385.
17. Dave VP, Majji AB, Suma N, Pappuru RR. A rare case of Aspergillus terreus endogenous endophthalmitis in a patient of acute lymphoid leukemia with good clinical outcome. Eye (Lond). 2011; 25:1094–1096.
18. Sen HN, Bodaghi B, Hoang PL, Nussenblatt R. Primary intraocular lymphoma: diagnosis and differential diagnosis. Ocul Immunol Inflamm. 2009; 17:133–141.
19. Drancourt M, Raoult D, Lepidi H, et al. Culture of Tropheryma whippelii from the vitreous fluid of a patient presenting with unilateral uveitis. Ann Intern Med. 2003; 139:1046–1047.
20. Finger PT, Papp C, Latkany P, et al. Anterior chamber paracentesis cytology (cytospin technique) for the diagnosis of intraocular lymphoma. Br J Ophthalmol. 2006; 90:690–692.
21. Matsuo T, Ichimura K, Ichikawa T, et al. Positron emission tomography/computed tomography after immunocytochemical and clonal diagnosis of intraocular lymphoma with vitrectomy cell blocks. J Clin Exp Hematop. 2009; 49:77–87.
22. Margolis L, Fraser R, Lichter A, Char DH. The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer. 1980; 45:688–692.
23. Jahnke K, Thiel E, Bechrakis NE, et al. Ifosfamide or trofosfamide in patients with intraocular lymphoma. J Neurooncol. 2009; 93:213–217.
24. De Smet MD, Stark-Vancs V, Kohler DR, et al. Intraocular levels of methotrexate after intravenous administration. Am J Ophthalmol. 1996; 121:442–444.
25. Batchelor TT, Kolak G, Ciordia R, et al. High-dose methotrexate for intraocular lymphoma. Clin Cancer Res. 2003; 9:711–715.
26. De Smet MD, Vancs VS, Kohler D, et al. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol. 1999; 83:448–451.
27. Tempescul A, Pradier O, Marianowski-Cochard C, et al. Combined therapy associating systemic platinum-based chemotherapy and local radiotherapy into the treatment of primary intraocular lymphoma. Ann Hematol. 2011; 90:1117–1118.